233 related articles for article (PubMed ID: 30500027)
1. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy.
Cai X; Luo Y; Song Y; Liu D; Yan H; Li H; Du D; Zhu C; Lin Y
Nanoscale; 2018 Dec; 10(48):22937-22945. PubMed ID: 30500027
[TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance.
Zhang W; Shen J; Su H; Mu G; Sun JH; Tan CP; Liang XJ; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13332-40. PubMed ID: 27164222
[TBL] [Abstract][Full Text] [Related]
3. Nanozyme Decorated Metal-Organic Frameworks for Enhanced Photodynamic Therapy.
Zhang Y; Wang F; Liu C; Wang Z; Kang L; Huang Y; Dong K; Ren J; Qu X
ACS Nano; 2018 Jan; 12(1):651-661. PubMed ID: 29290107
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic Platinum Nanozyme Immobilized on 2D Metal-Organic Frameworks for Mitochondrion-Targeting and Oxygen Self-Supply Photodynamic Therapy.
Gao Z; Li Y; Zhang Y; Cheng K; An P; Chen F; Chen J; You C; Zhu Q; Sun B
ACS Appl Mater Interfaces; 2020 Jan; 12(2):1963-1972. PubMed ID: 31873002
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
[TBL] [Abstract][Full Text] [Related]
6. Platinum-based nanocomposites loaded with MTH1 inhibitor amplify oxidative damage for cancer therapy.
Song Q; Yang W; Deng X; Zhang Y; Li J; Xing X; Chen W; Liu W; Hu H; Zhang Y
Colloids Surf B Biointerfaces; 2022 Oct; 218():112715. PubMed ID: 35932557
[TBL] [Abstract][Full Text] [Related]
7. Construction of PEGylated chlorin e6@CuS-Pt theranostic nanoplatforms for nanozymes-enhanced photodynamic-photothermal therapy.
Sheng Y; Ren Q; Tao C; Wen M; Qu P; Yu N; Li M; Chen Z; Xie X
J Colloid Interface Sci; 2023 Sep; 645():122-132. PubMed ID: 37146376
[TBL] [Abstract][Full Text] [Related]
8. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial-targeted multifunctional mesoporous Au@Pt nanoparticles for dual-mode photodynamic and photothermal therapy of cancers.
Song Y; Shi Q; Zhu C; Luo Y; Lu Q; Li H; Ye R; Du D; Lin Y
Nanoscale; 2017 Oct; 9(41):15813-15824. PubMed ID: 29018855
[TBL] [Abstract][Full Text] [Related]
10. Chlorin e6 conjugated silica nanoparticles for targeted and effective photodynamic therapy.
Bharathiraja S; Moorthy MS; Manivasagan P; Seo H; Lee KD; Oh J
Photodiagnosis Photodyn Ther; 2017 Sep; 19():212-220. PubMed ID: 28583295
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
12. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
[TBL] [Abstract][Full Text] [Related]
13. Integrating in situ formation of nanozymes with mesoporous polydopamine for combined chemo, photothermal and hypoxia-overcoming photodynamic therapy.
Hu X; Lu Y; Shi X; Yao T; Dong C; Shi S
Chem Commun (Camb); 2019 Dec; 55(98):14785-14788. PubMed ID: 31755884
[TBL] [Abstract][Full Text] [Related]
14. O
Lin T; Zhao X; Zhao S; Yu H; Cao W; Chen W; Wei H; Guo H
Theranostics; 2018; 8(4):990-1004. PubMed ID: 29463995
[TBL] [Abstract][Full Text] [Related]
15. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.
Zhang D; Wu M; Zeng Y; Wu L; Wang Q; Han X; Liu X; Liu J
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8176-87. PubMed ID: 25837008
[TBL] [Abstract][Full Text] [Related]
16. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
[TBL] [Abstract][Full Text] [Related]
17. Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging.
Yang Z; Wang J; Ai S; Sun J; Mai X; Guan W
Theranostics; 2019; 9(23):6809-6823. PubMed ID: 31660070
[TBL] [Abstract][Full Text] [Related]
18. Titania and silica nanoparticles coupled to Chlorin e6 for anti-cancer photodynamic therapy.
Youssef Z; Jouan-Hureaux V; Colombeau L; Arnoux P; Moussaron A; Baros F; Toufaily J; Hamieh T; Roques-Carmes T; Frochot C
Photodiagnosis Photodyn Ther; 2018 Jun; 22():115-126. PubMed ID: 29581041
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor.
Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J
ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181
[TBL] [Abstract][Full Text] [Related]
20. A Mitochondrial Oxidative Stress Amplifier to Overcome Hypoxia Resistance for Enhanced Photodynamic Therapy.
Dong P; Hu J; Yu S; Zhou Y; Shi T; Zhao Y; Wang X; Liu X
Small Methods; 2021 Sep; 5(9):e2100581. PubMed ID: 34928048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
